Podcast: Understanding Parkinson’s and genetics

Parkinson’s and genetics: “I wanted to know what kind of mutation I had, because I wanted to pay attention to the research.”
13 October 2025 Anthony Zahra
Podcasts

In this episode of the Parkinson’s Life podcast, we are exploring the world of genetics. Including the role it plays in Parkinson’s, and how research in this area could transform the future of care for everyone with the condition.

Genetics is emerging as one of the most promising areas of research, offering new insights into both the causes of Parkinson’s and potential treatments.

Our guests discuss how genetic mutations affect only 12% of people with Parkinson’s, yet this research is informing treatment approaches for everyone with the condition.

They also examine the challenges of ensuring genetic research reflects the global diversity of the Parkinson’s community.

Genetics testing and Parkinson’s – taking back control

During the episode, we meet Rita, a 42-year-old jewellery designer in Porto, who tells us about her Parkinson’s journey, and why she chose to have her genetics tested.

“I’m actually lucky, in a way, because most people with Parkinson’s are not 100% sure they have it,” she says. “In a way, I was relieved because I had spent one year trying to figure out what I had.”

Rita says the initial diagnosis came as a shock, but genetic testing has empowered her to take some control.

Latest Parkinson’s genetics research

We also meet two people who are at the forefront of the latest genetics research.

David Dexter, Director of Research at Parkinson’s UK, discusses the groundbreaking Landmark projectt, which will use donated brain tissue to unlock the secrets of genetic risk factors.

This research aims to correlate genetic changes with actual pathology occurring in the brain for the first time.

J Solle, from the Michael J Fox Foundation, introduces us to the Global Parkinson’s Genetics Program (GP2), an ambitious global programme designed to address the lack of diverse representation in genetic research.

GP2 is collecting genetic data from 250,000 individuals across more than 70 countries worldwide. As J puts it: “If you do not look in all ancestries, you’re simply going to miss something.”

Meet your hosts:

Amelia Hursey is Strategic Director at Parkinson’s Europe. She has a master’s in cognitive neuropsychology and has been involved in the neurodegenerative research world for 15 years.

Anthony Zahra is a broadcaster and journalist with more than 20 years’ experience in radio, digital and podcasting.

Listen to the full episode on Spotify, or on your podcast provider of choice. If you like what you’ve heard, please rate and review – it helps make sure others can find us.

Explore more of our Parkinson’s Life podcasts, with episodes covering Parkinson’s research, how to deal with “off” periods, sex and intimacy in Parkinson’s, and women and Parkinson’s. Never miss an episode by subscribing to the Parkinson’s Life podcast on Spotify, Apple Music, or your streaming service of choice.

Parkinson’s Europe is sharing this article for information purposes only; it does not represent Parkinson’s Europe’s views and is not an endorsement by Parkinson’s Europe of any particular treatments, therapies or products.